In the T2DM mouse model, we not only confirmed the abnormal expression of Plxnb2 and Ltbp3 but also observed coordinated changes in key upstream/downstream molecules, such as <i>TGF-β</i>, revealing a functional immune regulatory network. Here, PLXNB2 is linked to type 2 diabetes mellitus.